Director Dale B. Wolf filed an amended statement of changes in beneficial ownership with respect to AdaptHealth Corp. (NASDAQ:AHCO) on August 14, 2026, correcting the pricing detail of a common stock purchase originally reported on August 10, 2026.

Key Highlights

  • Purchase transaction: Dale B. Wolf acquired 20,000 shares of AdaptHealth Corp. common stock on August 6, 2026.
  • Price range corrected: The amendment updates the per-share price to reflect purchases made at prices ranging from $6.26 to $6.335, inclusive.
  • Direct holdings after transaction: Wolf directly holds 143,234 shares of common stock following the reported purchase.
  • Trust holdings: An additional 34,000 shares are held indirectly through the Dale B. Wolf Generation Skipping Trust, for which Wolf serves as investment manager.
  • Reporting person's role: Wolf is identified as a Director of AdaptHealth Corp. in the filing.

AdaptHealth Director Corrects Purchase Price in Amended Ownership Report

According to the amended filing, the original statement submitted on August 10, 2026 reported the transaction at an incorrect price. The amendment clarifies that the 20,000 shares of AdaptHealth Corp. common stock were acquired on August 6, 2026, through multiple transactions at prices ranging from $6.26 to $6.335 per share, inclusive. The filing notes that Wolf "undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."

AdaptHealth Corp., listed on NASDAQ under the ticker AHCO, is identified as the issuer in the filing. Following the reported purchase, Wolf's direct beneficial ownership stands at 143,234 shares of common stock. The filing also discloses 34,000 shares held indirectly through the Dale B. Wolf Generation Skipping Trust, an entity for which Wolf serves as investment manager, according to the footnotes. The amended filing was signed by Richard Rew as attorney-in-fact for Dale Wolf, with a power of attorney previously filed with the SEC on June 30, 2025.

What Was Disclosed

The amended filing corrects the per-share price of a 20,000-share common stock purchase by AdaptHealth Corp. director Dale B. Wolf, originally reported on August 10, 2026. Following the transaction, Wolf directly holds 143,234 shares, with an additional 34,000 shares held via a trust.